From Nasdaq: 2024-09-17 18:07:06

Bioengineering company Ginkgo Bioworks Holdings (NYSE: DNA) saw a 9% increase in stock price after unveiling new artificial intelligence (AI) products. These products include a protein large language model and a model application programming interface (API) to aid in medicine development using AI. Investors are hopeful about the company’s tech advancements.

Ginkgo Bioworks did not disclose financial details of its new AI products. Despite this, investors are optimistic about the company’s potential revenue streams. The Motley Fool Stock Advisor team excluded Ginkgo Bioworks from its list of 10 best stocks, emphasizing opportunities for significant returns. Investors are encouraged to consider other high-performing stocks for investment growth.

Stock Advisor highlights previous successful stock picks, like Nvidia in 2005, which resulted in a substantial return on investment. The service provides guidance on portfolio building and regular stock updates. Suzanne Frey from Alphabet sits on The Motley Fool’s board, and the company holds positions in Alphabet. The Motley Fool operates under a disclosure policy.



Read more at Nasdaq: Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today